1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Innovation Research (SBIR) Program Phase I (NHLBI) is sponsored by National Heart, Lung, and Blood Institute (NHLBI) - NIH. The NHLBI is interested in Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) activities that advance the prevention, diagnosis, and treatment of heart, lung, blood, and sleep disorders.
Phase I awards focus on the feasibility, technical merit, and commercial potential of research projects.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible United States small business concerns. Confirm the full requirements in the official notice before applying.
The current listing shows not specified, but Phase I awards typically do not exceed $323,090. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Small Business Innovation Research (SBIR) Program Phase I (NHLBI) are due April 5, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Small Business Innovation Research (SBIR) Program Phase I (NHLBI) is funded by National Heart, Lung, and Blood Institute (NHLBI) - NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.
Read articleNOT-OD-26-120 moved the DMS Plan elimination for NIH Career Development awards from October 12, 2027 to effective immediately. Active, pending, and future K applicants are all covered. Here is what changed, what did not, and where the paperwork will lag the policy.
Read articleNIH is carrying its emergency peer review modifications into the January 2027 Advisory Council with more than 35,000 applications in the queue. Discussion drops to 30-35 percent, the middle third becomes "competitive but not discussed" and stays eligible for funding, and the resume of discussion disappears from your summary statement. Here is what each change does to a real application.
Read article